CD8A and cancer: Upon activation by antigen presentation and co-stimulatory signals (CD28-CD80/86), CD8 + T cells proliferate and differentiate into the effector cells that respond to infection or cancer cells by releasing cytotoxic molecules, such as granzyme and perforin [91].